Karyopharm Therapeutics, Inc. (KPTI)
0.8022
-0.06
(-7.45%)
USD |
NASDAQ |
Oct 02, 16:00
0.8487
+0.05
(+5.80%)
Pre-Market: 20:00
Karyopharm Therapeutics Max Drawdown (5Y) : 99.44% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 99.44% |
| August 31, 2026 | 99.16% |
| July 31, 2026 | 99.11% |
| June 30, 2026 | 99.07% |
| May 31, 2026 | 99.07% |
| April 30, 2026 | 99.07% |
| March 31, 2026 | 99.07% |
| February 28, 2026 | 99.07% |
| January 31, 2026 | 99.07% |
| December 31, 2025 | 99.07% |
| November 30, 2025 | 99.07% |
| October 31, 2025 | 99.07% |
| September 30, 2025 | 99.07% |
| August 31, 2025 | 99.07% |
| July 31, 2025 | 99.07% |
| June 30, 2025 | 99.07% |
| May 31, 2025 | 99.07% |
| April 30, 2025 | 99.07% |
| March 31, 2025 | 99.01% |
| February 28, 2025 | 98.09% |
| January 31, 2025 | 97.85% |
| December 31, 2024 | 97.85% |
| November 30, 2024 | 97.56% |
| October 31, 2024 | 97.56% |
| September 30, 2024 | 97.56% |
| Date | Value |
|---|---|
| August 31, 2024 | 97.56% |
| July 31, 2024 | 97.56% |
| June 30, 2024 | 97.56% |
| May 31, 2024 | 97.56% |
| April 30, 2024 | 97.56% |
| March 31, 2024 | 97.56% |
| February 29, 2024 | 97.56% |
| January 31, 2024 | 97.56% |
| December 31, 2023 | 97.56% |
| November 30, 2023 | 97.56% |
| October 31, 2023 | 97.11% |
| September 30, 2023 | 95.89% |
| August 31, 2023 | 95.38% |
| July 31, 2023 | 94.62% |
| June 30, 2023 | 93.54% |
| May 31, 2023 | 91.99% |
| April 30, 2023 | 91.26% |
| March 31, 2023 | 91.26% |
| February 28, 2023 | 91.26% |
| January 31, 2023 | 91.26% |
| December 31, 2022 | 91.26% |
| November 30, 2022 | 91.26% |
| October 31, 2022 | 91.26% |
| September 30, 2022 | 91.26% |
| August 31, 2022 | 91.26% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Madrigal Pharmaceuticals, Inc. | 82.20% |
| Relay Therapeutics, Inc. | 96.75% |
| ACADIA Pharmaceuticals, Inc. | 77.18% |
| Alnylam Pharmaceuticals, Inc. | 58.17% |
| Savara, Inc. | 93.79% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -71.58 |
| Beta (5Y) | 1.036 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 91.86% |
| Historical Sharpe Ratio (5Y) | -0.6664 |
| Historical Sortino (5Y) | -1.110 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 40.82% |